<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.healthcarepackaging.com/industries/pharmaceuticals/article/22974207/ndc12-deadline-is-2033-hard-stop</loc><news:news><news:publication><news:name>Healthcare Packaging</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-16T14:22:00.000Z</news:publication_date><news:title>The NDC-12 Deadline Is 2033. Hard Stop</news:title></news:news><image:image><image:loc>https://img.healthcarepackaging.com/mindful/pmmi/workspaces/default/uploads/2026/09/chat-gpt-ndc.MOqligR3pT.png?auto=format%252Ccompress&amp;q=70</image:loc><image:caption>For pharmaceutical manufacturers still consumed with Drug Supply Chain Security Act (DSCSA) implementation and exception handling, another major industry transition is quickly moving onto the agenda: the shift to the 12-digit National Drug Code (NDC).</image:caption></image:image></url></urlset>